UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12B-25
NOTIFICATION OF LATE FILING
(Check one):
[x] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q [ ] Form N-SAR
For Period Ended: December 31, 1996
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates: not applicable
Part I - Registrant Information
Full Name of Registrant
INAMED CORPORATION
Address of Principal Executive Office:
3800 Howard Hughes Parkway, Suite #900
Las Vegas, Nevada 89109
Part II - Rules 12b-25 (b) and (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following
should be completed. (Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
[X] (b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, 11-K or From N-SAR, or
portion thereof will be filed on or before the fifteenth
calendar day following the prescribed due date; or the
subject quarterly report or transition report on Form 10-Q,
or portion thereof will be filed on or before the fifth
calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable
Part III - Narrative
State below in reasonable detail the reason why Form 10-K, 20-F, 11-K, 10-Q, N-
SAR or the transition report or portion thereof could not be filed within the
prescribed time period.
The Company has received comments from the Securities and Exchange
Commission on the Company's Registration Statement on Form S-3 filed January
15, 1997 which comments have necessitated amendments to the Company's third
quarter 1994 10-Q, 1995 10-KA and each of the 1996 10-Qs. Due to these
changes and the Company's efforts to amend its S-3 registration statement,
the 1996 10K could not be filed within the prescribed time period without
unreasonable effort or expense.
Part IV - Other Information
(1) Name and telephone number of person to contact in regard to this
notification
Samuel L. Simmons, Jr. , VP Finance, INAMED Corporation (702) 791-3388
(2) Have all other periodic reports required under section 13 or 15 (d) of the
Securities Exchange Act of 1934 or section 30 of the Investment Company Act of
1940 during the preceding 12 months or for such shorter periods that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[X] Yes [ ] NO
(3) Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earning statements to be included in the subject report or portion thereof?
[ ] Yes [X] NO
If so: attach an explanation of the anticipated change, both narratively and
quantitatively, and if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
INAMED CORPORATION
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: March 31, 1997 By /S/ DONALD K. MCGHAN
Chairman of the Board and President
